Melatonin protects ADSCs from ROS and enhances their therapeutic potency in a rat model of myocardial infarction

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 9, 2015, Pages 2232-2243

  Zhu, Ping ^a   Liu, Jianfeng ^a   Shi, Jinxin ^b   Zhou, Qian ^c   Liu, Jie ^a,g   Zhang, Xianwei ^d   Du, Zhiyan ^e   Liu, Qiaowei ^f   Guo, Yuanyuan ^b  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b Beijing Shijingshan Hospital ^*  (China)

^c The Center Hospital of Zhoukou   (China)

^d Chinese PLA   (China)

^e BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^f BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^g Peking University Civil Aviation School of Clinical Medicine   (China)

Author keywords

Adipose tissue derived MSCs; Apoptosis; Melatonin; Myocardial infarction; Rat model; Reactive oxygen species; Therapeutic strategy; Viability

Indexed keywords

CATALASE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; MELATONIN; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; SOMATOMEDIN C; SUPEROXIDE DISMUTASE; ANGIOGENIC FACTOR; ANTIOXIDANT; MITOGENIC AGENT;

ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOLUMINESCENCE; CELL ADHESION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACOTOMY; WESTERN BLOTTING; ADIPOSE TISSUE; ANIMAL; CARDIAC MUSCLE; CELL CULTURE; CELL PROTECTION; CELL SURVIVAL; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; HEART VENTRICLE; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT; STEM CELL; STEM CELL TRANSPLANTATION;

ADIPOSE TISSUE; ANGIOGENESIS INDUCING AGENTS; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; HEART VENTRICLES; MALE; MELATONIN; MITOGENS; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84940791111     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12610     Document Type: Article

References (49)

1. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007; 116: 2634-53.
2. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: a report from the american heart association. Circulation. 2013; 127: e6-245.
3. Mias C, Lairez O, Trouche E, et al. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction. Stem Cells. 2009; 27: 2734-43.
4. Liu M, Zhang P, Chen M, et al. Aging might increase myocardial ischemia / reperfusion-induced apoptosis in humans and rats. Age. 2012; 34: 621-32.
5. Liu J, Wang H, Wang Y, et al. The stem cell adjuvant with exendin-4 repairs the heart after myocardial infarction via stat3 activation. J Cell Mol Med. 2014; 18: 1381-91.
6. Liu J, Wang H, Wang Y, et al. Exendin-4 pretreated adipose derived stem cells are resistant to oxidative stress and improve cardiac performance via enhanced adhesion in the infarcted heart. PLoS ONE. 2014; 9: e99756.
7. Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004; 94: 92-5.
8. Ruan W, Pan CZ, Huang GQ, et al. Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging. Chin Med J. 2005; 118: 1175-81.
9. Katritsis DG, Sotiropoulou PA, Karvouni E, et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv. 2005; 65: 321-9.
10. Schachinger V, Erbs S, Elsasser A, et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the repair-ami trial. Eur Heart J. 2006; 27: 2775-83.
11. Tambara K, Sakakibara Y, Sakaguchi G, et al. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation. 2003; 108: II259-63.
12. Shi RZ, Li QP. Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease. Biochem Biophys Res Commun. 2008; 376: 247-50.
13. Angelos MG, Kutala VK, Torres CA, et al. Hypoxic reperfusion of the ischemic heart and oxygen radical generation. Am J Physiol Heart Circ Physiol. 2006; 290: H341-7.
14. Chang W, Song BW, Moon JY, et al. Anti-death strategies against oxidative stress in grafted mesenchymal stem cells. Histol Histopathol. 2013; 28: 1529-36.
15. Hass R, Lerner AB, Case JD, et al. Isolation of melatonin, the pineal gland factor that lightens melanocytes1. J Am Chem Soc. 1958; 80: 2587.
16. Reiter RJ, Tan DX, Manchester LC, et al. Melatonin and reproduction revisited. Biol Reprod. 2009; 81: 445-56.
17. Hardeland R, Cardinali DP, Srinivasan V, et al. Melatonin-a pleiotropic, orchestrating regulator molecule. Prog Neurobiol. 2011; 93: 350-84.
18. Reiter RJ, Tan DX, Rosales-Corral S, et al. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev Med Chem. 2013; 13: 373-84.
19. Wang FW, Wang Z, Zhang YM, et al. Protective effect of melatonin on bone marrow mesenchymal stem cells against hydrogen peroxide-induced apoptosis in vitro. J Cell Biochem. 2013; 114: 2346-55.
20. Tang Y, Cai B, Yuan F, et al. Melatonin pretreatment improves the survival and function of transplanted mesenchymal stem cells after focal cerebral ischemia. Cell Transplant. 2014; 23: 1279-91.
21. Mias C, Trouche E, Seguelas MH, et al. Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells. 2008; 26: 1749-57.
22. Carvalho PH, Daibert AP, Monteiro BS, et al. Differentiation of adipose tissue-derived mesenchymal stem cells into cardiomyocytes. Arq Bras Cardiol. 2013; 100: 82-9.
23. Cai H, Dikalov S, Griendling KK, et al. Detection of reactive oxygen species and nitric oxide in vascular cells and tissues: comparison of sensitivity and specificity. Methods Mol Med. 2007; 139: 293-311.
24. Song H, Cha MJ, Song BW, et al. Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells. 2010; 28: 555-63.
25. Liu Z, Wang H, Wang Y, et al. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials. 2012; 33: 3093-106.
26. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003; 114: 763-76.
27. Christman KL, Vardanian AJ, Fang Q, et al. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol. 2004; 44: 654-60.
28. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000; 101: 2981-8.
29. Chimenti I, Smith RR, Li TS, et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res. 2010; 106: 971-80.
30. Valina C, Pinkernell K, Song YH, et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J. 2007; 28: 2667-77.
31. Simpson D, Liu H, Fan TH, et al. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells. 2007; 25: 2350-7.
32. Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med. 2006; 12: 459-65.
33. Zimmermann WH, Melnychenko I, Wasmeier G, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med. 2006; 12: 452-8.
34. Rosova I, Dao M, Capoccia B, et al. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells. 2008; 26: 2173-82.
35. Wang JA, Chen TL, Jiang J, et al. Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol Sin. 2008; 29: 74-82.
36. Pons J, Huang Y, Arakawa-Hoyt J, et al. Vegf improves survival of mesenchymal stem cells in infarcted hearts. Biochem Biophys Res Commun. 2008; 376: 419-22.
37. Tavakoli F, Ostad SN, Khori V, et al. Outcome improvement of cellular cardiomyoplasty using triple therapy: mesenchymal stem cell+erythropoietin+vascular endothelial growth factor. Eur J Pharmacol. 2013; 714: 456-63.
38. Hahn JY, Cho HJ, Kang HJ, et al. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol. 2008; 51: 933-43.
39. Lim SY, Kim YS, Ahn Y, et al. The effects of mesenchymal stem cells transduced with akt in a porcine myocardial infarction model. Cardiovasc Res. 2006; 70: 530-42.
40. Li W, Ma N, Ong LL, et al. Bcl-2 engineered mscs inhibited apoptosis and improved heart function. Stem Cells. 2007; 25: 2118-27.
41. Tang J, Wang J, Guo L, et al. Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction. Mol Cells. 2010; 29: 9-19.
42. Tang J, Wang J, Zheng F, et al. Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats. Mol Cell Biochem. 2010; 339: 107-18.
43. Lu F, Zhao X, Wu J, et al. Mscs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis. Int J Cardiol. 2013; 167: 2524-32.
44. Tan DX, Zheng X, Kong J, et al. Fundamental issues related to the origin of melatonin and melatonin isomers during evolution: relation to their biological functions. Int J Mol Sci. 2014; 15: 15858-90.
45. Yip HK, Chang YC, Wallace CG, et al. Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury. J Pineal Res. 2013; 54: 207-21.
46. Chen YT, Chiang HJ, Chen CH, et al. Melatonin treatment further improves adipose-derived mesenchymal stem cell therapy for acute interstitial cystitis in rat. J Pineal Res. 2014; 57: 248-61.
47. Mukherjee D, Roy SG, Bandyopadhyay A, et al. Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms. J Pineal Res. 2010; 48: 251-62.
48. Hass R, Kasper C, Bohm S, et al. Different populations and sources of human mesenchymal stem cells (msc): a comparison of adult and neonatal tissue-derived msc. Cell Commun Signal. 2011; 9: 12.
49. Tang YL, Tang Y, Zhang YC, et al. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol. 2005; 46: 1339-50.